Company:  SELECTA BIOSCIENCES INC (SELB)
Form Type:  10-Q
Filing Date:  11/8/2019 
CIK:  0001453687 
Address:  480 ARSENAL WAY 
City, State, Zip:  WATERTOWN, Massachusetts 02472 
Telephone:  617-923-1400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.39  
Change: 
0.01 (0.73%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$66.99M
Trade SELB now with 

© 2019  
Description of Business
We are a clinical-stage biopharmaceutical company using our proprietary synthetic vaccine particle, or SVP, technology to discover and develop targeted therapies that are designed to modulate the immune system to effectively and safely treat rare and serious diseases. Many such diseases are treated with biologic therapies that are foreign to the patient's immune system and therefore elicit an undesired immune response. Of particular concern are anti-drug antibodies, or ADAs, which are often produced by the immune system in response to biologic therapy and can adversely affect the efficacy and safety of treatment. Our SVP technology is a highly flexible platform that is capable of incorporating a wide range of antigens and immunomodulators, potentially allowing for the development of products that either induce antigen-specific immune tolerance (tolerogenic SVP technology) or activate the immune system (stimulatory SVP technology).
Register and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to Consolidated Financial Statements (Unaudited)
          CASH FLOW
        OPTIONS AGGREGATE
      Item 2. Management's Discussion and Analysis of Financial ...
      FINANCIAL STATEMENTS
        CASH FLOW
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    PART II-OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 6. Exhibits
    EXHIBIT INDEX
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 10.3
  EXHIBIT 31.1
    CERTIFICATIONS
  EXHIBIT 31.2
    CERTIFICATIONS
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO